Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsKarkhadi

    Karkhadi

    Jump to

    • USFDA inspects Alembic Pharma's facility in Karkhadi, Gujarat

      "The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals active pharmaceutical ingredient (API) facility located at Karkhadi from January 13 to January 17, 2020," it said.

    • Dr Reddy's Lab recalls 58,656 bottles of Lansoprazole in US

      The US Food and Drug Administration has classified the recall of the drug as 'Class II' which indicates a remote chance of severe adverse consequences or death due to the product flaw.

    • Sun Pharma gets import alert from USFDA

      Sun Pharmaceutical Industries is negatively impacted because of news with regards to the USFDA import alert on its Karkhadi facility in Gujarat, which manufactures cephalosporin API as well as formulations.

    • USFDA ban may not affect Sun Pharma financially: JM Fin

      However, softer issues may possibly drag the management bandwidth as this is the first time the company has received an import alert.

    • USFDA slaps import alert on Sun Pharma's Karkhadi plant

      Indian pharmaceutical company Sun Pharma has received an USFDA import alert for all products manufactured at its Karkhadi unit. The company manufactures API and formulations at its Karkhadi Unit.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347